| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma, Inc. | Director | Ordinary Shares | 32,954 | $321,301 | $9.75 | 19 May 2025 | Direct |
| Theravance Biopharma, Inc. | Director | Share Option (Right to Buy) | 24,258 | 19 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | 19 May 2025 | 2 | $0 | 4 | Director | 21 May 2025, 19:10 |
| TBPH | Theravance Biopharma, Inc. | 08 May 2024 | 2 | $0 | 4 | Director | 10 May 2024, 18:04 |
| TBPH | Theravance Biopharma, Inc. | 21 Dec 2023 | 4 | $0 | 4 | Director | 26 Dec 2023, 18:09 |
| TBPH | Theravance Biopharma, Inc. | 21 Dec 2023 | 0 | $0 | 3 | Director | 26 Dec 2023, 18:06 |